市場調査レポート

商品コード

1724777

創薬サービスの市場規模、シェア、成長分析、プロセス別、タイプ別、治療領域別、薬剤の種類別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Drug Discovery Services Market Size, Share, and Growth Analysis, By Process, By Type, By Therapeutic Area, By Drug Type, By Technology, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年05月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 775,496円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 907,184円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,038,872円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.32円

全表示
概要
目次

概要

サンプル依頼リストに入れる

創薬サービスの世界市場規模は、2023年に43億米ドルと評価され、2024年の46億4,000万米ドルから2032年には86億米ドルに成長し、予測期間中（2025-2032年）のCAGRは8.0％で成長する見通しです。

神経変性疾患、がん、希少遺伝子疾患、心血管疾患など、さまざまなアンメットメディカルニーズを背景に、革新的な医薬品に対する需要は依然として大きいです。新たな疾患の出現に伴い、新薬開発への取り組みが活発化していることから、創薬サービス市場は大きな成長を遂げる見通しです。この複雑なプロセスでは、毒物学、創薬化学、薬理学といった分野の専門家が協力する必要があり、しばしば研究機関や製薬企業はコストと時間の効率化のためにこれらのサービスを外注することになります。大手製薬企業は、効率性を高め、希少疾患や希少疾病用医薬品に特化した新たな収益源を開拓するため、研究開発に多額の投資を行っています。しかし、厳しい規制や熟練した専門家の不足といった課題は、市場の拡大に影響を及ぼす可能性があります。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Charles River Laboratories（USA）
WuXi AppTec（China）
Thermo Fisher Scientific Inc.（USA）
Evotec SE（Germany）
Pharmaron（China）
Labcorp（USA）
Syngene International Limited（India）
Eurofins Scientific（Luxembourg）
Jubilant Biosys Limited（India）
Curia Global, Inc.（USA）
GenScript（USA）
Frontage Holdings Corporation（USA）
Piramal Enterprises Ltd.（India）
Aragen Life Sciences Ltd.（India）
Sygnature Discovery（UK）
Selvita SA（Poland）
Viva Biotech（China）
TCG Lifesciences Pvt. Ltd.（India）
Medicilon（China）
Sai Life Sciences Limited（India）

結論と提言

Product Code: SQMIG35J2059

Global Drug Discovery Services Market size was valued at USD 4.3 billion in 2023 and is poised to grow from USD 4.64 billion in 2024 to USD 8.6 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The demand for innovative drugs remains significant, driven by various unmet medical needs across neurodegenerative diseases, cancers, rare genetic disorders, and cardiovascular issues. As new diseases emerge, the drug discovery services market is poised for considerable growth due to heightened efforts in novel drug development. This complex process necessitates collaboration among experts in fields such as toxicology, medicinal chemistry, and pharmacology, often leading research institutions and pharmaceutical companies to outsource these services for cost and time efficiencies. Major pharmaceutical firms are investing heavily in R&D to enhance efficiency and tap into fresh revenue streams focused on rare diseases and orphan drug initiatives. However, challenges such as stringent regulations and a shortage of skilled professionals may affect market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segments Analysis

Global Drug Discovery Services Market is segmented by Process, Type, Therapeutic Area, Drug Type, Technology, End User and region. Based on Process, the market is segmented into Target Selection, Target Validation, Hit-To-Lead Identification, Candidate Validation and Others. Based on Type, the market is segmented into Medicinal Chemistry, Biology Services, Drug Metabolism, Pharmaceutical Services and Pharmacokinetics. Based on Therapeutic Area, the market is segmented into Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes and Others. Based on Drug Type, the market is segmented into Small Molecules and Biologics. Based on Technology, the market is segmented into High Throughput Screening, Biochips, Pharmacogenetics, Nanotechnology and Spectroscopy. Based on End User, the market is segmented into Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies and Research Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Services Market

The global drug discovery services market is significantly driven by the rising prevalence of chronic diseases such as diabetes, dementia, and cardiovascular conditions, which collectively account for over 40 million deaths annually, representing seven out of ten fatalities worldwide. As the incidence of these chronic illnesses continues to escalate, it is anticipated that the demand for drug discovery services will expand throughout the forecast period. This surge in chronic diseases not only highlights the urgent need for effective therapeutic interventions but also presents lucrative economic opportunities for companies specializing in drug discovery, as the market increasingly seeks innovative medication solutions.

Restraints in the Global Drug Discovery Services Market

One of the key constraints affecting the Global Drug Discovery Services market is the stringent focus of regulatory agencies on ensuring the safety and efficacy of drugs before approval. Although these thorough processes are essential for maintaining confidence in medicine quality, they significantly escalate the costs associated with drug development, ultimately resulting in higher prices for the end products. This is particularly crucial in price-sensitive emerging economies, where the elevated costs can substantially hinder the adoption and accessibility of new medicines, thereby impacting overall market growth and limiting patient access to vital treatments.

Market Trends of the Global Drug Discovery Services Market

The Global Drug Discovery Services market is experiencing significant growth, driven by an escalating demand for novel therapies that address chronic diseases and improve patient outcomes. As global healthcare systems expand and evolve, pharmaceutical companies are increasingly investing in clinical trials to seek innovative solutions. This trend is further bolstered by advancements in technologies such as AI and genomics, which streamline the drug discovery process. Consequently, the market is witnessing a surge in collaboration between biopharmaceutical firms and contract research organizations (CROs), facilitating the rapid progression of drug development and increasing the overall market value.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis

Global Drug Discovery Services Market Size by Process & CAGR (2025-2032)

Market Overview
Target Selection
Target Validation
Hit-To-Lead Identification
Candidate Validation
Others

Global Drug Discovery Services Market Size by Type & CAGR (2025-2032)

Market Overview
Medicinal Chemistry
Biology Services
Drug Metabolism
Pharmaceutical Services
Pharmacokinetics

Global Drug Discovery Services Market Size by Therapeutic Area & CAGR (2025-2032)

Market Overview
Oncology
Neurology
Cardiovascular Disease
Respiratory Disease
Diabetes
Others

Global Drug Discovery Services Market Size by Drug Type & CAGR (2025-2032)

Market Overview
Small Molecules
Biologics

Global Drug Discovery Services Market Size by Technology & CAGR (2025-2032)

Market Overview
High Throughput Screening
Biochips
Pharmacogenetics
Nanotechnology
Spectroscopy

Global Drug Discovery Services Market Size by End User & CAGR (2025-2032)

Market Overview
Hospital & Clinics
Pharmaceutical Companies
Biotechnology Companies
Research Institute

Global Drug Discovery Services Market Size & CAGR (2025-2032)

North America (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
- US
- Canada
Europe (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Process, Type, Therapeutic Area, Drug Type, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Charles River Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evotec SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labcorp (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syngene International Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Biosys Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curia Global, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Holdings Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Piramal Enterprises Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aragen Life Sciences Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sygnature Discovery (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Selvita SA (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viva Biotech (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TCG Lifesciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medicilon (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sai Life Sciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

創薬サービスの市場規模、シェア、成長分析、プロセス別、タイプ別、治療領域別、薬剤の種類別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Drug Discovery Services Market Size, Share, and Growth Analysis, By Process, By Type, By Therapeutic Area, By Drug Type, By Technology, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

創薬サービス市場規模：プロセス別& CAGR（2025-2032）

創薬サービス市場規模：タイプ別& CAGR（2025-2032）

創薬サービス市場規模：治療領域別& CAGR（2025-2032）

創薬サービス市場規模：薬剤の種類別& CAGR（2025-2032）

創薬サービス市場規模：技術別& CAGR（2025-2032）

創薬サービス市場規模：エンドユーザー別& CAGR（2025-2032）

創薬サービス市場規模：地域別& CAGR（2025-2032）